https://www.selleckchem.com/pr....oducts/tucidinostat-
Conclusion MYOF may serve as a diagnostic biomarker of tumor progression and a potential therapeutic target in ccRCC.Background/aim Pancreatic cancer is one of the deadliest forms of cancer and ranks among the leading causes of cancer-related death worldwide. The most common histological type is ductal adenocarcinoma (PDAC), accounting for approximately 95% of cases. Deregulation of protein synthesis has been found to be closely related to cancer. The rate-limiting step of translation is initiation, which is regulated by